U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H21BrF3N4O4S.K
Molecular Weight 649.521
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAPRISARTAN POTASSIUM

SMILES

[K+].CCC1=NC(C2CC2)=C(N1CC3=CC4=C(OC(=C4Br)C5=CC=CC=C5[N-]S(=O)(=O)C(F)(F)F)C=C3)C(N)=O

InChI

InChIKey=IASZJGRIPLTJMA-UHFFFAOYSA-N
InChI=1S/C25H21BrF3N4O4S.K/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29;/h3-7,10-11,14H,2,8-9,12H2,1H3,(H2,30,34);/q-1;+1

HIDE SMILES / InChI
Saprisartan (formerly known as GR 138950) was developed as a potent long-lasting angiotensin II (AT1) receptor antagonist with high oral bioavailability. The drug was used for the treatment of hypertension and heart failure. However, these studies were discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P30556
Gene ID: 185.0
Gene Symbol: AGTR1
Target Organism: Homo sapiens (Human)
PubMed

PubMed

TitleDatePubMed
The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
1998-11
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
1997-12
Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
1995-02
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.
1994-09-16
Patents
Name Type Language
SAPRISARTAN POTASSIUM
USAN   WHO-DD  
USAN  
Official Name English
GR-138950C
Preferred Name English
SAPRISARTAN POTASSIUM [USAN]
Common Name English
GR138950C
Code English
1-((3-BROMO-2-(2-(((TRIFLUORO-METHYL)SULFONYL)AMINO)PHENYL)-5-BENZOFURANYL)METHYL)-4-CYCLOPROPYL-2-ETHYL-1H-IMIDAZOLE-5-CARBOXAMIDE POTASSIUM
Systematic Name English
Saprisartan potassium [WHO-DD]
Common Name English
1-[[3-Bromo-2-[O-(1,1,1-(trifluoromethanesulfonamido)phenyl]-5-benzofuranyl]methyl]-4-cyclopropyl-2-ethylimidazole-5-carboxamide, monopotassium salt
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66930
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
Code System Code Type Description
USAN
GG-106
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID40163421
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
PUBCHEM
23678978
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
ChEMBL
CHEMBL305544
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
DRUG BANK
DBSALT001863
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
CAS
146613-90-3
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
SMS_ID
100000084945
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
FDA UNII
T28707PG7T
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
NCI_THESAURUS
C152298
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
MESH
C089586
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY
EVMPD
SUB04326MIG
Created by admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
PRIMARY